Prof. Makoto Arita

 

 

 

Academic Degree(s)

Ph.D.

 

E-mail

makoto.arita@riken.jp

 

Current Position

  • Team leader, Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences (IMS), Yokohama, Japan
  • Professor, Division of physiological Chemistry and Metabolism, Keio University Faculty of Pharmacy, Tokyo, Japan

 

Professional Experience

  • 1997-2000 Assistant Professor, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
  • 2003-2006 Instructor, Brigham&Women’s Hospital/Harvard Medical School, Boston, USA
  • 2007-2014 Associate Professor, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan

 

Education & Training

  • 1994-1997 Ph.D. Student, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
  • 2000-2003 Postdoctoral Fellow, Brigham&Women’s Hospital/Harvard Medical School, Boston, USA

 

Awards

  • 2016    Lands Science Award, Japan Society for Lipid Nutrition
  • 2009    Young Scientists’ Prize, Ministry of Education, Culture, Sports, Science and Technology, Japan
  • 2005    Young Investigator Award, 9th International Conference of  Eicosanoids other Bioactive Lipids in Cancer, Inflammation & Related Diseases (San Francisco)

 

Research Grants

  • Grant-in-aid for Scientific Research in Innovative Areas “Lipoquality” (#15H05897, 15H05898)
  • Grant-in-aid for Scientific Research (B)(# 15H04648)
  • Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry

 

Committee & Membership

  • Vice President, International Society for Omega-3 Research
  • Director, Japan Society for Biomedical Mass Spectrometry
  • Councilor, Japan Society for Lipid Nutrition

 

Selected Publication

  • Isobe Y, Itagaki M, Ito Y, Naoe S, Kojima K, Ikeguchi M, *Arita M. Comprehensive analysis of the mouse cytochrome P450 family responsible for omega-3 epoxidation of eicosapentaenoic acid. Sci Rep 8, 7954 (2018)
  • Sakayori N, Kikkawa T, Tokuda H, Kiryu E, Yoshizaki K, Kawashima H, Yamada T, Arai H, Kang JX, Katagiri H, Shibata H, Innis SM, Arita M, *Osumi N. Maternal dietary balance between omega-6 and omega-3 polyunsaturated fatty acids impairs neocortical development via epoxy metabolites. Stem Cells 34, 470-482 (2016)
  • *Kunisawa J, *Arita M, Hayasaka T, Harada T, Iwamoto R, Nagasawa R, Shikata S, Nagatake T, Suzuki H, Hashimoto E, Kurashima Y, Suzuki Y, Arai H, Setou M, Kiyono H. Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicostetraenoic acid in the gut. Sci Rep 5, 9750 (2015)
  • Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, *Arita M. 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med 211, 1673-1687 (2014)
  • Tani Y, Isobe Y, Imoto Y, Segi-Nishida E, Sugimoto Y, Arai H, *Arita M. Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice. FASEB J 28, 4036-4043 (2014)
  • Kubota T, *Arita M, Isobe Y, Iwamoto R, Goto T, Yoshioka T, Urabe D, Inoue M, Arai H. Eicosapentaenoic acid is converted via omega-3 epoxygenation to anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid. FASEB J 28, 586-593 (2014)
  • Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanabe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, *Imai Y. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153, 112-125 (2013)
  • Isobe Y, *Arita M, Matsueda S, Iwamoto R, Fujihara T, Nakanishi H, Taguchi R, Masuda K, Sasaki K, Urabe D, Inoue M, Arai H. Identification and structure determination of novel anti-inflammatory mediator resolvin E3: 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem 287, 10525-10534 (2012)
  • Yamada T, Tani Y, Nakanishi H, Taguchi R, *Arita M, Arai H. Eosinophils promote resolution of acute peritonitis by producing pro-resolving mediators in mice. FASEB J 25 561-568 (2011)
  • Schwab JM, Chiang N, Arita M, *Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007)